Vascular endothelial growth factor expression correlates with hematogenous metastasis and prognosis in colorectal carcinoma

S Kang, K Maeda, Y Chung, N Onoda… - Oncology …, 1997 - spandidos-publications.com
We investigated the expression of vascular endothelial growth factor (VEGF) in 175
colorectal carcinomas by immunohistochemistry. VEGF expression was correlated with …

Significance of vascular endothelial growth factor expression in colorectal cancer

S Zhong, Z Zhang, S Li - Zhonghua nei ke za zhi, 2001 - europepmc.org
Objective To investigate the expression of vascular endothelial growth factor (VEGF) mRNA
in colorectal cancer (CRC) and its relation with the clinicopathologic features and explore …

[HTML][HTML] Investigating the predictive value of vascular endothelial growth factor in the evaluation of treatment efficacy and prognosis for patients with non-surgical …

Z Kong, F Sun, Q Meng, M Zhou, J Yu, L Hu - Frontiers in Oncology, 2022 - frontiersin.org
In this study, we aim to investigate the predictive value of serum vascular endothelial growth
factor (VEGF) in evaluating treatment efficacy and long-term prognosis for patients with non …

Expression and clinical significance of VEGF-C mRNA and CD 31 in esophageal squamous cell carcinoma

MX Ding, JC Li - Shi yan Sheng wu xue bao, 2003 - europepmc.org
To investigate the expression of vascular endothelial growth factor-C (VEGF-C) mRNA and
CD 31 in esophageal squamous cell carcinoma (ESCC) and its promotion of lymphatic …

Altered expression of endogenous soluble vascular endothelial growth factor receptor-2 is involved in the progression of esophageal squamous cell carcinoma

ZY Wu, T Chen, Q Zhao, JH Huang… - … of Histochemistry & …, 2013 - journals.sagepub.com
Endogenous soluble vascular endothelial growth factor receptor-2 (esVEGFR-2), a new
splicing variant of VEGFR-2, was shown to be the first endogenous specific inhibitor of …

Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.

N Minagawa, Y Nakayama, K Hirata, K Onitsuka… - Anticancer …, 2002 - europepmc.org
BACKGROUND: Vascular endothelial growth factor (VEGF) is thought to be the most potent
angiogenic factor and may contribute to the progression of various cancers. In colorectal …

[HTML][HTML] The prognostic value of the combination of low VEGFR-1 and High VEGFR-2 expression in endothelial cells of colorectal cancer

N D'Haene, C Koopmansch, YR Van Eycke… - International journal of …, 2018 - mdpi.com
Research on tumor angiogenesis has mainly focused on the vascular endothelial growth
factor (VEGF) family and on methods to block its actions. However, reports on VEGF receptor …

Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma

X Li, X Su, C Yan, Y Ma, H Li, J Xia, H Li… - Journal of Cancer …, 2023 - Springer
Vascular endothelial growth factor (VEGF) is related to the radiation resistance of tumors,
resulting in the failure of tumor radiotherapy. The purpose of this study was to discuss the …

Lymphangiogenesis in Esophageal Adenocarcinomas--Lymphatic Vessel Density as Prognostic Marker in Esophageal Adenocarcinoma

RS Saad, JL Lindner, Y Liu… - American journal of …, 2009 - academic.oup.com
We studied tumor lymphatic vascular density (LVD) as a predictive marker for the risk of
lymph node (LN) metastasis and its relationship to other prognostic parameters and survival …

Vascular Endothelial Growth Factor Expression and Neovascularization in Non—Small Cell Lung Carcinoma

IH Ozbudak, G Ozbilim… - … journal of surgical …, 2009 - journals.sagepub.com
The prognostic significance of microvascular density (MVD) and vascular endothelial growth
factor (VEGF) expression were investigated in 15 patients with adenocarcinoma (AC) and 15 …